Skip to content

Multicenter prospective observational study stratifying phenotype of idiopathic cardiomyopathy patients with 99mTc-MIBI myocardial scintigraphy

Multicenter prospective observational study stratifying phenotype of idiopathic cardiomyopathy patients with 99mTc-MIBI myocardial scintigraphy - Multicenter prospective observational study with 99mTc-MIBI scintigraphy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000044206
Enrollment
120
Registered
2021-05-17
Start date
2021-06-23
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Idiopathic cardiomyopathy

Interventions

None listed

Sponsors

Osaka University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Patients without coronary artery disease (LVEF<40% in echocardiography) who consent to participation and have a scheduled 99mTc-MIBI scintigraphy 2.Patients who have a scheduled optimal therapy for heart failure and myocardial dysfunction

Exclusion criteria

Exclusion criteria: 1.Patients with systemic disease with poor prognosis (within 1 year) 2.No follow-up 3.Patients without standard treatment 4.Patients judged to be inappropriate by investigator

Design outcomes

Primary

MeasureTime frame
Predictability of LVRR after 1 year based on indices obtained from 99mTc-MIBI scintigraphy

Countries

Japan

Contacts

Public ContactTomohito Ohtani

Osaka University Graduate School of Medicine Department of Cardiovascular Medicine

ohtani@cardiology.med.osaka-u.ac.jp06-6879-3631

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026